189 related articles for article (PubMed ID: 20620489)
1. The influence of hepatitis C infection activity on oxidative stress markers and erythropoietin requirement in hemodialysis patients.
Tutal E; Sezer S; Ibis A; Bilgic A; Ozdemir N; Aldemir D; Haberal M
Transplant Proc; 2010 Jun; 42(5):1629-36. PubMed ID: 20620489
[TBL] [Abstract][Full Text] [Related]
2. Influence of oxidative stress and inflammation on rHuEPO requirements of hemodialysis patients with CRP values "in normal range".
Tutal E; Sezer S; Bilgic A; Aldemir D; Turkoglu S; Demirel O; Ozdemir N; Haberal M
Transplant Proc; 2007 Dec; 39(10):3035-40. PubMed ID: 18089316
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C infection in hemodialysis patients: Protective against oxidative stress?
Sezer S; Tutal E; Aldemir D; Türkoglu S; Demirel OU; Afsar B; Ozdemir FN; Haberal M
Transplant Proc; 2006 Mar; 38(2):406-10. PubMed ID: 16549132
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].
Acar A; Görenek L; Aydin A; Eyigün CP; Eken A; Sayal A; Pahsa A
Mikrobiyol Bul; 2009 Jul; 43(3):411-23. PubMed ID: 19795616
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C viral infection in a Chinese hemodialysis unit.
Li H; Wang SX
Chin Med J (Engl); 2010 Dec; 123(24):3574-7. PubMed ID: 22166633
[TBL] [Abstract][Full Text] [Related]
6. Effect of anti-HCV positivity on markers of malnutrition and inflammation in hemodialysis patients.
Zumrutdal A; Ozer B; Singan M; Micozkadioglu H; Sezer S; Ozdemir FN; Haberal M
Ren Fail; 2007; 29(1):85-90. PubMed ID: 17365915
[TBL] [Abstract][Full Text] [Related]
7. Levels of plasma malondialdehyde and erythrocyte antioxidant enzyme activities in patients with chronic hepatitis B.
Demirdag K; Yilmaz S; Ozdarendeli A; Ozden M; Kalkan A; Kilic SS
Hepatogastroenterology; 2003; 50(51):766-70. PubMed ID: 12828081
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
9. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied.
Espinosa M; Martin-Malo A; Alvarez de Lara MA; Soriano S; Aljama P
Clin Nephrol; 2000 Aug; 54(2):151-6. PubMed ID: 10968693
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between cardiovascular complication and inflammation, oxidative stress of patient with maintenance hemodialysis].
Zuo C; Qiu HY; Li Z; Xie XS; Fan JM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 39(1):119-21, 129. PubMed ID: 18390217
[TBL] [Abstract][Full Text] [Related]
11. Relationships between plasma ferritin and aminotransferase profile in haemodialysis patients with hepatitis C virus.
Caramelo C; Albalate M; Bermejillo T; Navas S; Ortiz A; de Sequera P; Casado S; Carreño V
Nephrol Dial Transplant; 1996 Sep; 11(9):1792-6. PubMed ID: 8918624
[TBL] [Abstract][Full Text] [Related]
12. [Does long-term erythropoietin therapy influence the prevalence of serum markers of hepatitis B and C in haemodialysed uraemic patients?].
Mesjasz J; Wiecek A; Gonciarz Z; Mazur W; Kokot F
Pol Merkur Lekarski; 2004 Apr; 16(94):362-7. PubMed ID: 15517934
[TBL] [Abstract][Full Text] [Related]
13. Effect of hepatitis C infection on anemia in hemodialysis patients.
Khurana A; Nickel AE; Narayanan M; Foulks CJ
Hemodial Int; 2008 Jan; 12(1):94-9. PubMed ID: 18271849
[TBL] [Abstract][Full Text] [Related]
14. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR
J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052
[TBL] [Abstract][Full Text] [Related]
15. Vitamins B depletion, lower iron status and decreased antioxidative defense in patients with chronic hepatitis C treated by pegylated interferon alfa and ribavirin.
Lin CC; Yin MC
Clin Nutr; 2009 Feb; 28(1):34-8. PubMed ID: 19042060
[TBL] [Abstract][Full Text] [Related]
16. Association of hepatitis C virus infection and malnutrition-inflammation complex syndrome in maintenance hemodialysis patients.
Tsai HB; Chen PC; Liu CH; Hung PH; Chen MT; Chiang CK; Kao JH; Hung KY
Nephrol Dial Transplant; 2012 Mar; 27(3):1176-83. PubMed ID: 21896499
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory characteristics of acute hepatitis C in patients with end-stage renal disease on hemodialysis.
Lemos LB; Perez RM; Matos CA; Silva IS; Silva AE; Ferraz ML
J Clin Gastroenterol; 2008 Feb; 42(2):208-11. PubMed ID: 18209594
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis status and mortality in hemodialysis population.
Santoro D; Mazzaglia G; Savica V; Li Vecchi M; Bellinghieri G
Ren Fail; 2009; 31(1):6-12. PubMed ID: 19142803
[TBL] [Abstract][Full Text] [Related]
19. Effect of hepatitis C virus on C-reactive protein and interleukin-6 in hemodialysis patients.
Afzal N; Abbas S; Ahmed A; Arif M; Javeed K
Iran J Kidney Dis; 2011 Jul; 5(3):182-6. PubMed ID: 21525578
[TBL] [Abstract][Full Text] [Related]
20. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
